Zheng J, Dhakal H, Qing E, Shrestha R, Geller A, Morrissey S
J Clin Invest. 2025; 135(4).
PMID: 39773555
PMC: 11827850.
DOI: 10.1172/JCI188222.
Dutta S, Zhu Y, Almuntashiri S, Peh H, Zuniga J, Zhang D
Am J Physiol Lung Cell Mol Physiol. 2024; 328(1):L60-L74.
PMID: 39585242
PMC: 11905806.
DOI: 10.1152/ajplung.00104.2024.
Huang Y, Li L, Chen R, Yu L, Zhao S, Jia Y
Front Immunol. 2024; 15:1460990.
PMID: 39575248
PMC: 11578956.
DOI: 10.3389/fimmu.2024.1460990.
Ruminski P, Rettig M, Dipersio J
Biomolecules. 2024; 14(8).
PMID: 39199390
PMC: 11353233.
DOI: 10.3390/biom14081003.
Chen B, Ran Q, Chen X, Deng Z, Zhou R, Zhang Y
Biochem Biophys Rep. 2024; 39:101782.
PMID: 39108621
PMC: 11300898.
DOI: 10.1016/j.bbrep.2024.101782.
The story of clobenpropit and CXCR4: can be an effective drug in cancer and autoimmune diseases?.
Abbasifard M, Bagherzadeh K, Khorramdelazad H
Front Pharmacol. 2024; 15:1410104.
PMID: 39070795
PMC: 11272485.
DOI: 10.3389/fphar.2024.1410104.
Expanding CXCR4 variant landscape in WHIM syndrome: integrating clinical and functional data for variant interpretation.
Zmajkovicova K, Nykamp K, Blair G, Yilmaz M, Walter J
Front Immunol. 2024; 15:1411141.
PMID: 39040098
PMC: 11260667.
DOI: 10.3389/fimmu.2024.1411141.
Intracerebellar administration of the chemokine Cxcl3 reduces the volume of medulloblastoma lesions at an advanced stage by promoting the migration and differentiation of preneoplastic precursor cells.
Ceccarelli M, Rossi S, Bonaventura F, Massari R, DElia A, Soluri A
Brain Pathol. 2024; 35(1):e13283.
PMID: 38946128
PMC: 11669415.
DOI: 10.1111/bpa.13283.
Tumor cells express and maintain HMGB1 in the reduced isoform to enhance CXCR4-mediated migration.
Pirani E, Paparoditis P, Pecoraro M, Danelon G, Thelen M, Cecchinato V
Front Immunol. 2024; 15:1358800.
PMID: 38803493
PMC: 11128625.
DOI: 10.3389/fimmu.2024.1358800.
CXCR4: From Signaling to Clinical Applications in Neuroendocrine Neoplasms.
Sanchis-Pascual D, Del Olmo-Garcia M, Prado-Wohlwend S, Zac-Romero C, Segura Huerta A, Hernandez-Gil J
Cancers (Basel). 2024; 16(10).
PMID: 38791878
PMC: 11120359.
DOI: 10.3390/cancers16101799.
A novel transmembrane CXCR4 variant that expands the WHIM genotype-phenotype paradigm.
Zmajkovicova K, Pawar S, Sharapova S, Geier C, Wiest I, Nguyen C
Blood Adv. 2024; 8(14):3754-3759.
PMID: 38768429
PMC: 11296240.
DOI: 10.1182/bloodadvances.2023011875.
CXCR4: from B-cell development to B cell-mediated diseases.
Giorgiutti S, Rottura J, Korganow A, Gies V
Life Sci Alliance. 2024; 7(6).
PMID: 38519141
PMC: 10961644.
DOI: 10.26508/lsa.202302465.
Extramedullary hematopoiesis in cancer.
Barisas D, Choi K
Exp Mol Med. 2024; 56(3):549-558.
PMID: 38443597
PMC: 10985111.
DOI: 10.1038/s12276-024-01192-4.
The Role of Chemokines in Orchestrating the Immune Response to Pancreatic Ductal Adenocarcinoma.
Lekan A, Weiner L
Cancers (Basel). 2024; 16(3).
PMID: 38339310
PMC: 10854906.
DOI: 10.3390/cancers16030559.
CXCR4 Is a Potential Target for Anti-HIV Gene Therapy.
Prokopovich A, Litvinova I, Zubkova A, Yudkin D
Int J Mol Sci. 2024; 25(2).
PMID: 38256260
PMC: 10816112.
DOI: 10.3390/ijms25021187.
Different methods of bone marrow harvesting influence cell characteristics and purity, affecting clinical outcomes.
Caradonna E, Mormone E, Centritto E, Mazzanti A, Papini S, Fanelli M
JVS Vasc Sci. 2023; 4:100130.
PMID: 38058747
PMC: 10696233.
DOI: 10.1016/j.jvssci.2023.100130.
Bayesian traction force estimation using cell boundary-dependent force priors.
Fujikawa R, Okimura C, Kozawa S, Ikeda K, Inagaki N, Iwadate Y
Biophys J. 2023; 122(23):4542-4554.
PMID: 37915171
PMC: 10719052.
DOI: 10.1016/j.bpj.2023.10.032.
Correlation between SDF-1α, CD34 positive hematopoietic stem cells and CXCR4 expression with liver fibrosis in CCl4 rat model.
Abubakr S, Hazem N, Sherif R, Elhawary A, Botros K
BMC Gastroenterol. 2023; 23(1):323.
PMID: 37730560
PMC: 10512633.
DOI: 10.1186/s12876-023-02932-y.
Differentiation Induction of Mesenchymal Stem Cells by a Au Delivery Platform.
Yang M, Chiu C, Ke Y, Yang Y, Chang K, Chen C
Cells. 2023; 12(14).
PMID: 37508556
PMC: 10378595.
DOI: 10.3390/cells12141893.
Severe CD8+ T Lymphopenia in WHIM Syndrome Caused by Selective Sequestration in Primary Immune Organs.
Majumdar S, Pontejo S, Jaiswal H, Gao J, Salancy A, Stassenko E
J Immunol. 2023; 210(12):1913-1924.
PMID: 37133343
PMC: 10247468.
DOI: 10.4049/jimmunol.2200871.